CN102399220A - 三并环类PI3K和mTOR双重抑制剂 - Google Patents
三并环类PI3K和mTOR双重抑制剂 Download PDFInfo
- Publication number
- CN102399220A CN102399220A CN2010102824065A CN201010282406A CN102399220A CN 102399220 A CN102399220 A CN 102399220A CN 2010102824065 A CN2010102824065 A CN 2010102824065A CN 201010282406 A CN201010282406 A CN 201010282406A CN 102399220 A CN102399220 A CN 102399220A
- Authority
- CN
- China
- Prior art keywords
- substituted
- methyl
- alkyl
- naphthyridines
- dihydro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 CC(C)(C)OC(N(CC1)CCC1NC(C(C=O)=C*1)=C(*2)C1=CC=C2c1cc(C=N)c(NCc(cc2)ccc2OC)nc1)=O Chemical compound CC(C)(C)OC(N(CC1)CCC1NC(C(C=O)=C*1)=C(*2)C1=CC=C2c1cc(C=N)c(NCc(cc2)ccc2OC)nc1)=O 0.000 description 1
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010102824065A CN102399220A (zh) | 2010-09-15 | 2010-09-15 | 三并环类PI3K和mTOR双重抑制剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010102824065A CN102399220A (zh) | 2010-09-15 | 2010-09-15 | 三并环类PI3K和mTOR双重抑制剂 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN102399220A true CN102399220A (zh) | 2012-04-04 |
Family
ID=45881923
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010102824065A Pending CN102399220A (zh) | 2010-09-15 | 2010-09-15 | 三并环类PI3K和mTOR双重抑制剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102399220A (zh) |
Cited By (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013071698A1 (zh) * | 2011-11-17 | 2013-05-23 | 山东轩竹医药科技有限公司 | 三环类PI3K和/或mTOR抑制剂 |
WO2014040373A1 (zh) * | 2012-09-12 | 2014-03-20 | 山东轩竹医药科技有限公司 | PI3K和/或mTOR抑制剂 |
WO2014154026A1 (zh) * | 2013-03-28 | 2014-10-02 | 山东轩竹医药科技有限公司 | PI3K和/或mTOR抑制剂的前药 |
US9266892B2 (en) | 2012-12-19 | 2016-02-23 | Incyte Holdings Corporation | Fused pyrazoles as FGFR inhibitors |
US9388185B2 (en) | 2012-08-10 | 2016-07-12 | Incyte Holdings Corporation | Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors |
US9533954B2 (en) | 2010-12-22 | 2017-01-03 | Incyte Corporation | Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3 |
US9533984B2 (en) | 2013-04-19 | 2017-01-03 | Incyte Holdings Corporation | Bicyclic heterocycles as FGFR inhibitors |
US9580423B2 (en) | 2015-02-20 | 2017-02-28 | Incyte Corporation | Bicyclic heterocycles as FGFR4 inhibitors |
US9611267B2 (en) | 2012-06-13 | 2017-04-04 | Incyte Holdings Corporation | Substituted tricyclic compounds as FGFR inhibitors |
US9708318B2 (en) | 2015-02-20 | 2017-07-18 | Incyte Corporation | Bicyclic heterocycles as FGFR4 inhibitors |
US9890156B2 (en) | 2015-02-20 | 2018-02-13 | Incyte Corporation | Bicyclic heterocycles as FGFR4 inhibitors |
US10611762B2 (en) | 2017-05-26 | 2020-04-07 | Incyte Corporation | Crystalline forms of a FGFR inhibitor and processes for preparing the same |
US10851105B2 (en) | 2014-10-22 | 2020-12-01 | Incyte Corporation | Bicyclic heterocycles as FGFR4 inhibitors |
US11174257B2 (en) | 2018-05-04 | 2021-11-16 | Incyte Corporation | Salts of an FGFR inhibitor |
US11407750B2 (en) | 2019-12-04 | 2022-08-09 | Incyte Corporation | Derivatives of an FGFR inhibitor |
US11466004B2 (en) | 2018-05-04 | 2022-10-11 | Incyte Corporation | Solid forms of an FGFR inhibitor and processes for preparing the same |
US11566028B2 (en) | 2019-10-16 | 2023-01-31 | Incyte Corporation | Bicyclic heterocycles as FGFR inhibitors |
US11591329B2 (en) | 2019-07-09 | 2023-02-28 | Incyte Corporation | Bicyclic heterocycles as FGFR inhibitors |
US11607416B2 (en) | 2019-10-14 | 2023-03-21 | Incyte Corporation | Bicyclic heterocycles as FGFR inhibitors |
US11628162B2 (en) | 2019-03-08 | 2023-04-18 | Incyte Corporation | Methods of treating cancer with an FGFR inhibitor |
US11897891B2 (en) | 2019-12-04 | 2024-02-13 | Incyte Corporation | Tricyclic heterocycles as FGFR inhibitors |
US11939331B2 (en) | 2021-06-09 | 2024-03-26 | Incyte Corporation | Tricyclic heterocycles as FGFR inhibitors |
-
2010
- 2010-09-15 CN CN2010102824065A patent/CN102399220A/zh active Pending
Cited By (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10213427B2 (en) | 2010-12-22 | 2019-02-26 | Incyte Corporation | Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3 |
US10813930B2 (en) | 2010-12-22 | 2020-10-27 | Incyte Corporation | Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3 |
US9533954B2 (en) | 2010-12-22 | 2017-01-03 | Incyte Corporation | Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3 |
WO2013071698A1 (zh) * | 2011-11-17 | 2013-05-23 | 山东轩竹医药科技有限公司 | 三环类PI3K和/或mTOR抑制剂 |
US20150166539A1 (en) * | 2011-11-17 | 2015-06-18 | Xuanzhu Pharma Co., Ltd. | Three-ring pi3k and/or mtor inhibitor |
CN103224496A (zh) * | 2011-11-17 | 2013-07-31 | 山东轩竹医药科技有限公司 | 三环类PI3K和/或mTOR抑制剂 |
US9284315B2 (en) | 2011-11-17 | 2016-03-15 | Zuanzhu Pharma Co., Ltd. | Three-ring PI3K and/or mTOR inhibitor |
CN103224496B (zh) * | 2011-11-17 | 2016-06-29 | 山东轩竹医药科技有限公司 | 三环类PI3K和/或mTOR抑制剂 |
US10131667B2 (en) | 2012-06-13 | 2018-11-20 | Incyte Corporation | Substituted tricyclic compounds as FGFR inhibitors |
US9611267B2 (en) | 2012-06-13 | 2017-04-04 | Incyte Holdings Corporation | Substituted tricyclic compounds as FGFR inhibitors |
US11053246B2 (en) | 2012-06-13 | 2021-07-06 | Incyte Corporation | Substituted tricyclic compounds as FGFR inhibitors |
US11840534B2 (en) | 2012-06-13 | 2023-12-12 | Incyte Corporation | Substituted tricyclic compounds as FGFR inhibitors |
US9745311B2 (en) | 2012-08-10 | 2017-08-29 | Incyte Corporation | Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors |
US9388185B2 (en) | 2012-08-10 | 2016-07-12 | Incyte Holdings Corporation | Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors |
CN104884456A (zh) * | 2012-09-12 | 2015-09-02 | 山东轩竹医药科技有限公司 | PI3K和/或mTOR抑制剂 |
US9365572B2 (en) * | 2012-09-12 | 2016-06-14 | Xuanzhu Pharma Co., Ltd. | PI3K and/or mTOR inhibitor |
JP2015531779A (ja) * | 2012-09-12 | 2015-11-05 | 山東軒竹医薬科技有限公司 | PI3Kおよび/またはmTOR阻害剤 |
CN104884456B (zh) * | 2012-09-12 | 2017-08-11 | 山东轩竹医药科技有限公司 | PI3K和/或mTOR抑制剂 |
US20150239885A1 (en) * | 2012-09-12 | 2015-08-27 | Xuanzhu Pharma Co., Ltd. | Pi3k and/or mtor inhibitor |
WO2014040373A1 (zh) * | 2012-09-12 | 2014-03-20 | 山东轩竹医药科技有限公司 | PI3K和/或mTOR抑制剂 |
US9266892B2 (en) | 2012-12-19 | 2016-02-23 | Incyte Holdings Corporation | Fused pyrazoles as FGFR inhibitors |
CN105121442A (zh) * | 2013-03-28 | 2015-12-02 | 山东轩竹医药科技有限公司 | PI3K和/或mTOR抑制剂的前药 |
CN105121442B (zh) * | 2013-03-28 | 2017-05-17 | 山东轩竹医药科技有限公司 | PI3K和/或mTOR抑制剂的前药 |
WO2014154026A1 (zh) * | 2013-03-28 | 2014-10-02 | 山东轩竹医药科技有限公司 | PI3K和/或mTOR抑制剂的前药 |
US10040790B2 (en) | 2013-04-19 | 2018-08-07 | Incyte Holdings Corporation | Bicyclic heterocycles as FGFR inhibitors |
US10450313B2 (en) | 2013-04-19 | 2019-10-22 | Incyte Holdings Corporation | Bicyclic heterocycles as FGFR inhibitors |
US9533984B2 (en) | 2013-04-19 | 2017-01-03 | Incyte Holdings Corporation | Bicyclic heterocycles as FGFR inhibitors |
US11530214B2 (en) | 2013-04-19 | 2022-12-20 | Incyte Holdings Corporation | Bicyclic heterocycles as FGFR inhibitors |
US10947230B2 (en) | 2013-04-19 | 2021-03-16 | Incyte Corporation | Bicyclic heterocycles as FGFR inhibitors |
US10851105B2 (en) | 2014-10-22 | 2020-12-01 | Incyte Corporation | Bicyclic heterocycles as FGFR4 inhibitors |
US11173162B2 (en) | 2015-02-20 | 2021-11-16 | Incyte Corporation | Bicyclic heterocycles as FGFR4 inhibitors |
US10016438B2 (en) | 2015-02-20 | 2018-07-10 | Incyte Corporation | Bicyclic heterocycles as FGFR4 inhibitors |
US10632126B2 (en) | 2015-02-20 | 2020-04-28 | Incyte Corporation | Bicyclic heterocycles as FGFR4 inhibitors |
US10738048B2 (en) | 2015-02-20 | 2020-08-11 | Incyte Corporation | Bicyclic heterocycles as FGFR4 inhibitors |
US9708318B2 (en) | 2015-02-20 | 2017-07-18 | Incyte Corporation | Bicyclic heterocycles as FGFR4 inhibitors |
US10251892B2 (en) | 2015-02-20 | 2019-04-09 | Incyte Corporation | Bicyclic heterocycles as FGFR4 inhibitors |
US9801889B2 (en) | 2015-02-20 | 2017-10-31 | Incyte Corporation | Bicyclic heterocycles as FGFR4 inhibitors |
US11014923B2 (en) | 2015-02-20 | 2021-05-25 | Incyte Corporation | Bicyclic heterocycles as FGFR4 inhibitors |
US9580423B2 (en) | 2015-02-20 | 2017-02-28 | Incyte Corporation | Bicyclic heterocycles as FGFR4 inhibitors |
US11667635B2 (en) | 2015-02-20 | 2023-06-06 | Incyte Corporation | Bicyclic heterocycles as FGFR4 inhibitors |
US10214528B2 (en) | 2015-02-20 | 2019-02-26 | Incyte Corporation | Bicyclic heterocycles as FGFR4 inhibitors |
US9890156B2 (en) | 2015-02-20 | 2018-02-13 | Incyte Corporation | Bicyclic heterocycles as FGFR4 inhibitors |
US11472801B2 (en) | 2017-05-26 | 2022-10-18 | Incyte Corporation | Crystalline forms of a FGFR inhibitor and processes for preparing the same |
US10611762B2 (en) | 2017-05-26 | 2020-04-07 | Incyte Corporation | Crystalline forms of a FGFR inhibitor and processes for preparing the same |
US11466004B2 (en) | 2018-05-04 | 2022-10-11 | Incyte Corporation | Solid forms of an FGFR inhibitor and processes for preparing the same |
US11174257B2 (en) | 2018-05-04 | 2021-11-16 | Incyte Corporation | Salts of an FGFR inhibitor |
US11628162B2 (en) | 2019-03-08 | 2023-04-18 | Incyte Corporation | Methods of treating cancer with an FGFR inhibitor |
US11591329B2 (en) | 2019-07-09 | 2023-02-28 | Incyte Corporation | Bicyclic heterocycles as FGFR inhibitors |
US11607416B2 (en) | 2019-10-14 | 2023-03-21 | Incyte Corporation | Bicyclic heterocycles as FGFR inhibitors |
US11566028B2 (en) | 2019-10-16 | 2023-01-31 | Incyte Corporation | Bicyclic heterocycles as FGFR inhibitors |
US11407750B2 (en) | 2019-12-04 | 2022-08-09 | Incyte Corporation | Derivatives of an FGFR inhibitor |
US11897891B2 (en) | 2019-12-04 | 2024-02-13 | Incyte Corporation | Tricyclic heterocycles as FGFR inhibitors |
US11939331B2 (en) | 2021-06-09 | 2024-03-26 | Incyte Corporation | Tricyclic heterocycles as FGFR inhibitors |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102399220A (zh) | 三并环类PI3K和mTOR双重抑制剂 | |
CN102399233B (zh) | PI3K和mTOR双重抑制剂类化合物 | |
KR102007056B1 (ko) | 과증식성 질환 치료시 Bub1 키나제 저해제로 사용하기 위한 치환된 벤질인다졸 | |
JP6355648B2 (ja) | Wntシグナル伝達経路の3−(ベンゾイミダゾール−2−イル)−インダゾール阻害剤およびそれらの治療的使用 | |
TWI527800B (zh) | 作為聚(二磷酸腺苷酸-核醣)聚合酶(parp)之抑制劑之1-(芳基甲基)喹唑啉-2,4(1h,3h)-二酮及其應用 | |
KR100441362B1 (ko) | 혈관 형성 억제 활성을 갖는 프탈라진 | |
RU2559895C2 (ru) | Азотосодержащие производные гетероарилов | |
CA2409743C (en) | Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors | |
WO2020249079A1 (zh) | 一种shp2磷酸酶变构抑制剂 | |
JP6564406B2 (ja) | カゼインキナーゼ1デルタ/イプシロン阻害剤としてのイミダゾ−ピリダジン誘導体 | |
CN101790527A (zh) | Rho激酶的苯并噻吩抑制剂 | |
CA2905751A1 (en) | Novel compounds and compositions for inhibition of fasn | |
CN102361859A (zh) | 用作Raf激酶抑制剂的杂芳基化合物 | |
CA2784393A1 (en) | Compounds and methods for kinase modulation, and indications therefor | |
JP2010209121A (ja) | 新規のピリドピラジンのキナーゼモジュレーターとしての使用 | |
CN102159573A (zh) | 作为nadph氧化酶抑制剂的吡唑并吡啶衍生物 | |
WO2016208592A1 (ja) | 二環性複素環アミド誘導体 | |
JP2021535213A (ja) | AhRモジュレーターとしてのテトラヒドロピリドピリミジン誘導体 | |
JP2021503013A (ja) | Acss2阻害剤およびその使用方法 | |
CN107056755B (zh) | 五元杂环酰胺类wnt通路抑制剂 | |
CN104837844A (zh) | 作为酪蛋白激酶1 d/e抑制剂的吡唑取代的咪唑并哌嗪 | |
JP2010505922A (ja) | 新規なイミダゾロン誘導体、医薬としてのそれの製造、医薬組成物、およびタンパク質キナーゼ阻害薬、特にcdc7阻害薬としてのそれの使用 | |
TW202104212A (zh) | 以雜環化合物作為激酶抑制劑的治療用途 | |
CN103102352B (zh) | 酪氨酸激酶抑制剂吲哚满酮衍生物 | |
CN103664734B (zh) | 杂环羟肟酸类化合物及其药用组合物和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
ASS | Succession or assignment of patent right |
Owner name: SHANDONG XUANZHU MEDICAL SCI-TECH CO., LTD. Free format text: FORMER OWNER: HUANG ZHENHUA Effective date: 20120723 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20120723 Address after: Tianchen Avenue in Ji'nan high tech Development Zone of Shandong province 250101 City No. 2518 Applicant after: Shandong Xuanzhu Medical Technology Co., Ltd. Address before: Tianchen Avenue in Ji'nan high tech Development Zone of Shandong province 250101 City No. 2518 Applicant before: Huang Zhenhua |
|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20120404 |